Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma

doi:10.16352/j.issn.1001-6325.2023.09.1417

Abstract

Abstract: Objective To detect the expression level of circular RNA (circRNA) hsa_circ_005230 in the plasma of primary hepatocellular carcinoma (HCC), and to explore its clinical value in the diagnosis and prognosis of HCC. Methods The non-coding RNA high-throughput sequencing data in the GEO database was used to screen the circRNA expression in HCC (cancer tissue/paracancerous tissue). RT-qPCR was used to detect hsa_circ_005230 in the plasma of 60 HCC patients, 30 hepatitis B patients and 30 healthy people. Expression levels and their relationship with clinicopathological characteristics of HCC patients were evaluated. The receiver operating characteristic(ROC) curve to evaluate the clinical value of hsa_circ_005230 in the diagnosis of HCC. Survival analysis was performed by Kaplan-Meier method, and multivariate prognostic analysis was performed by Cox regression. Results The most significant up-regulated expression was found in hsa_circ_005230 from the GEO database. The expression level of hsa_circ_005230 in plasma of HCC patients was significantly higher than that of hepatitis B group and healthy control group (P＜0.01); The increase of hsa_circ_005230 expression was related to tumor size (P＜0.05) and to the stage of tumor lymph node metastasis(P＜0.01); ROC analysis showed that the area under the ROC curve (AUC) of plasma hsa_circ_005230 in differentiating HCC from healthy people was 0.69, the sensitivity was 70%,and the specificity was 82 %.The overall survival rate of patients with high hsa_circ_005230 level was significantly lower than that of patients with low hsa_circ_005230 level. Univariate analysis showed that alpa-fetoprotein(AFP)(P＜0.01) and hsa_circ_005230 (P＜0.01) were related factors affecting the prognosis of HCC. Cox multivariate analysis revealed that hsa_circ_005230 was an independent prognostic indicator in HCC patients. Conclusions The hsa_circ_005230 may be used as a new biological marker for the diagnosis and prognostic evaluation of HCC.

Key words: hepatocellular carcinoma, circular RNA, hsa_circ_005230, diagnosis, prognosis

CLC Number:

R622
R73

Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing. Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.09.1417

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I9/1417

References

[1]Yang L, Song C, Chen Y, et al. Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236[J]. J Cell Biochem, 2019, 120:15553-15560.
[2]Zhao M, Dong G, Meng Q, et al. Circ_OMER1 enhances the inhibition of miR22 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells[J]. J Cell Biochem, 2020, 121:4440-4449.
[3]Afrin R, Arumugam S, Rahman A, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation[J]. Int Immunopharmacol, 2017, 44:174-182.
[4]Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer[J]. Breast Cancer, 2018, 25:1-7.
[5]赵钰珊,冀梦蝶,董昱诚,等.肝细胞癌中EZH2基因相关的表观遗传调控机制[J].基础医学与临床,2022,42:864-870.
[6]Yao T, Chen Q, Fu L, et al. Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases[J]. Hepatol Res, 2017, 47:497-504.
[7]Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer[J]. Mol Cancer, 2017, 16:94-101.
[8]黄海良,丁伟伟,李冬雪. CRNDE过表达促进人肝癌细胞系HepG2增殖和迁移[J].基础医学与临床, 2020, 40:219-223.
[9]Qi H, Sun Y, Jiang Y, et al. Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-1238[J]. J Cell Biochem, 2019, 5:11-19.
[10]Zhang LW, Wang B, Yang JX, et al. Circ-PRMT5 stimulates migration in esophageal cancer by binding miR-203[J]. Eur Rev Med Pharmacol Sci, 2020, 24:9965-9972.
[11]Yang L, Song C, Chen Y, et al. Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236[J]. J Cell Biochem, 2019, 120:15553-15560.
[12]Shen GQ, Girelli D, Li L, et al. A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 gene.[J]. Circ Cardiovasc Genet, 2014, 7:514-520.
[13]Shaohang, Cai, Zejin, et al. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome:[J]. United European Gastroenterol J, 2018, 6:558-566.
[14]Frisk P, Aggefors K, Cars T, et al. Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden[J]. Eur J Clin Pharmacol, 2018, 74:971-978.
[15]Mónica G, Sandra G, Miguel HK, et al. Differential roles, crosstalk and response to the antifungal protein AfpB in the three mitogen-activated protein kinases (MAPK) pathways of the citrus postharvest pathogen penicillium digitatum.[J]. Fungal Genet Biol, 2018, 124:17-28.